TY - JOUR T1 - Iatrogenic Cushing syndrome caused by ocular glucocorticoids in a child JF - BMJ Case Reports DO - 10.1136/bcr.11.2008.1224 VL - 2009 SP - bcr1120081224 AU - Maria Francesca Messina AU - Mariella Valenzise AU - Salvatore Aversa AU - Teresa Arrigo AU - Filippo De Luca Y1 - 2009/01/01 UR - http://casereports.bmj.com/content/2009/bcr.11.2008.1224.abstract N2 - A boy aged 7.6 years presented to our Unit of Paediatric Endocrinology for evaluation of obesity. Progressive weight gain (10 kg) started 6 months earlier after an accidental penetrating orbital injury on the right eye. During this period the child has been treated with oral betamethasone (0.5 mg/day) for 1 month and dexamethasone 2% ocular drops (2 hourly by day) for 6 months. Physical examination showed he was 113.5 cm in height (−1.5 SD), weight 36.0 kg, blood pressure 110/90 mmHg (90th centile), body mass index 28 (+5 SD), truncal obesity, buffalo hump, “moon-face”, increased lanugo hair and supraclavicular fullness. Endocrinological work-up revealed undetectable levels of basal adrenocorticotropic hormone (ACTH), basal and ACTH-stimulated cortisol and 24 h urine excretion cortisol, confirming the diagnosis of iatrogenic Cushing syndrome. The abrupt withdrawal of ocular glucocorticoids by the parents evoked two adrenal crises; 4 months later the patient recovered. In conclusion, we would alert doctors that every formulation of glucocorticoids, no ocular drops excluded, can determine severe systemic side effects and iatrogenic Cushing syndrome. ER -